Company Search:
Advanced Search
Sponsored Links
Astellas Pharma Incorporated Company Snapshot
Astellas Pharma Incorporated operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Astellas Pharma Incorporated with three other companies in this sector in Japan: Daiichi Sankyo Company Limited (2017 sales of 955.12 billion Japanese Yen [US$8.86 billion] of which 93% was prescription drugs), Otsuka Holdings Company Limited (1.24 trillion Japanese Yen [US$11.51 billion] of which 62% was Medical related business), and Takeda Pharmaceutical Company Limited (1.73 trillion Japanese Yen [US$16.07 billion] of which 91% was Pharmaceutical Business).

Sales Analysis. Astellas Pharma Incorporated reported sales of ¥1.31 trillion (US$12.17 billion) for the fiscal year ending March of 2017. This represents a decrease of 4.4% versus 2016, when the company's sales were ¥1.37 trillion. Contributing to the drop in overall sales was the 14.4% decline in Vesicare, from ¥135.64 billion to ¥116.08 billion. There were also decreases in sales in Other (down 3.1% to ¥757.36 billion) and Prograf (down 8.5% to ¥186.16 billion) . However, these declines were partially offset by the increase in sales of Xtandi (up 0.0% to ¥252.08 billion) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Astellas Pharma Incorporated
  Stock Performance Chart for Astellas Pharma Incorporated
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 1,582.00
(Figures in Japanese Yen)
1 Week 1.3%   13 Weeks 0.9%  
4 Weeks 14.3%   52 Weeks 3.8%  
Astellas Pharma Incorporated Key Data:
  Ticker: 4503 Country: Japan
  Exchanges: PAR TYO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 1,311,665,000,000
(Year Ending Jan 2018).
Employees: 17,202
  Currency: Japanese Yen Market Cap: 3,188,780,473,312
  Fiscal Yr Ends: March Shares Outstanding: 2,015,664,016
  Share Type: Common Closely Held Shares: 16,841,965
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.